Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline2022년 6월 업데이트: 코로나바이러스 질병 2019(COVID-19)로 입원한 성인 관리: 유럽 호흡기 학회 생활 지침Editorial Published on 2022-08-102022-09-11 Journal: The European Respiratory Journal [Category] Fulltext, SARS, 바이오마커, [키워드] anti-IL-6 anticoagulation Baricitinib coronavirus disease Corticosteroids COVID-19 guideline European hospitalised hospitalised patient Hospitalised patients management monoclonal antibodies Non-invasive respiratory support recommendation respiratory Society with COVID-19 [DOI] 10.1183/13993003.00803-2022 PMC 바로가기 [Article Type] Editorial
Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label, randomised clinical trialRandomized Controlled Trial Published on 2022-08-042022-10-04 Journal: The European Respiratory Journal [Category] Fulltext, SARS, 임상, [키워드] 1:1 28-day mortality 95% CI age assigned Clinical improvement clinical status clinical trial Controlled trial coronavirus disease COVID-19 death demonstrated Dexamethasone discharged Effect Efficacy enrolled Evidence High dose High-dose high-dose group hospitalised hospitalised COVID-19 patient hospitalised patient low dose low-dose male moderate no significant difference Open-label outcome oxygen Oxygen therapy Patient performed Pneumonia Primary outcome randomisation randomised Randomly receive reduced secondary seven-point ordinal scale severe COVID-19 Time to recovery worsening [DOI] 10.1183/13993003.02518-2021 PMC 바로가기 [Article Type] Randomized Controlled Trial
Comparison of trends in Clostridioides difficile infections in hospitalised patients during the first and second waves of the COVID-19 pandemic: A retrospective sentinel surveillance studyResearch article Published on 2022-08-012022-10-05 Journal: The Lancet Regional Health - Europe [Category] 진단, [키워드] 95%CI adjusted Analysis caused CDI change Characteristics Clostridioides difficile Clostridioides difficile infection Complete COVID-19 COVID-19 pandemic Delayed diagnostics Epidemiology Factors finding FIVE funding hospital hospitalised hospitalised patient hygiene incidence rate nine Patient patients retrospective SARS-CoV-2 second wave social distancing Surveillance Symptoms trend [DOI] 10.1016/j.lanepe.2022.100424 [Article Type] Research article
Statin and aspirin as adjuvant therapy in hospitalised patients with SARS-CoV-2 infection: a randomised clinical trial (RESIST trial)Randomized Controlled Trial Published on 2022-07-092022-10-05 Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 임상, [키워드] 95% CI addition adverse events Anti-inflammatory anti-thrombotic properties Aspirin assigned benefit C-reactive protein clinical Clinical deterioration clinical trial Combination control group COVID-19 discharge group hospitalisation hospitalised patient improvement Infection interleukin-6 Mild Moderate COVID-19 no difference number observational study occurred Open-label Patient positive COVID-19 Prevent Primary outcome randomised randomised controlled trial Randomly receive Registered registry RT-PCR SARS-CoV-2 scale secondary outcome serum Serum IL-6 serum interleukin-6 level shown single-center Standard of care statin the study group therapy Treatment Trial troponin I WHO WHO ordinal scale WHO ordinal scale. [DOI] 10.1186/s12879-022-07570-5 PMC 바로가기 [Article Type] Randomized Controlled Trial
Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis코로나19로 입원한 환자에서 토실리주맙, 사릴루맙, 28일 후 모든 원인 사망률 사이의 연관성: 네트워크 메타 분석Meta-Analysis Published on 2022-07-082022-09-11 Journal: PLoS ONE [Category] meta-analysis, 임상, 진단, [키워드] 28-day mortality all-cause mortality antagonist association choice clinician Consistency Corticosteroid Corticosteroids COVID-19 patient deaths demonstrated dependent on Effect eligible patient Evidence hospitalised patient Hospitalised patients in-hospital mortality inconsistency initiated interleukin-6 interleukin-6 receptor invasive ventilation Meta-analysis Network meta-analysis Non-invasive not dependent Odds ratio Odds ratios P-value Patient Placebo randomisation randomised randomised comparison receiving receptor antagonist REMAP-CAP REMAP-CAP trial sarilumab Tocilizumab Trial usual care Ventilation with COVID-19 [DOI] 10.1371/journal.pone.0270668 PMC 바로가기 [Article Type] Meta-Analysis
Blood supply, transfusion demand and mortality in Italian patients hospitalised during nine months of COVID-19 pandemicObservational Study Published on 2022-07-012022-10-04 Journal: Blood transfusion = Trasfusione del sangue [Category] 임상, [키워드] Apulia Blood blood component blood donation blood supply Care Clinical outcome COVID patient COVID-19 pandemic COVID-19 patient COVID-19 patients eight fatality Fatality rate hospital hospitalised hospitalised patient ICUs implementation intensive care unit internal Italian patient Kaplan-Meier analysis maintain material Medicine men Mortality nine pandemic Patient performed present proportion RBC red blood cell reduction in Research retrospective significantly higher significantly lower transfused university [DOI] 10.2450/2021.0173-21 PMC 바로가기 [Article Type] Observational Study
Persistent Antiphospholipid Antibodies Are Not Associated With Worse Clinical Outcomes in a Prospective Cohort of Hospitalised Patients With SARS-CoV-2 Infection지속적인 항인지질 항체는 SARS-CoV-2 감염으로 입원한 환자의 예상 코호트에서 더 나쁜 임상 결과와 관련이 없습니다Article Published on 2022-06-222022-09-12 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Admission admitted to ICU age analysed antibody antiphospholipid antibodies antiphospholipid syndrome - immunology association Barcelona clinical Clinical outcome clinical outcomes Cohort conducted COVID COVID - 19 COVID-19 patients criteria Diagnosis elevated hospitalisation hospitalised COVID-19 patient hospitalised patient ICU ICU admission IgG immunology intensive care men outcome Patient patients persistence persistent positive positive result Prevalence prevalent Prospective Prospective Study SARS-CoV-2 separated severe respiratory failure suffered syndrome tested thrombosis thrombosis - immunology. ventilatory with COVID-19 [DOI] 10.3389/fimmu.2022.911979 PMC 바로가기 [Article Type] Article
The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 20202020년 상반기 영국의 COVID-19 전염병에 대한 병원 획득 감염의 기여도Article Published on 2022-06-182022-09-11 Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 치료기술, [키워드] Admission caused community transmission COVID-19 COVID-19 cases COVID-19 epidemic COVID-19 patient dataset determine discharge distribution England English First wave hospital Hospital-acquired infection hospital-acquired infections hospitalised hospitalised COVID-19 patient hospitalised COVID-19 patients hospitalised patient Hospitalised patients Incubation period individual Infection Inpatient Inpatients less Mathematical modelling measure National Nosocomial transmission Patient proportion recorded resulting SARS-CoV-2 SARS-COV-2 infection symptom onset symptomatic symptomatic SARS-CoV-2 infection the epidemic Transmission Trust [DOI] 10.1186/s12879-022-07490-4 PMC 바로가기 [Article Type] Article
Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trialsResearch article Published on 2022-06-032022-10-05 Journal: EClinicalMedicine [Category] 임상, [키워드] 28-day mortality 95% CI Analysis Anti-inflammatory Anti-viral Baricitinib COVID COVID19 database death Dexamethasone discharge disease duration of hospitalisation ECMO Efficacy finding funding hospitalised patient improved mortality IMV inhibitor Invasive mechanical ventilation Jak Janus kinase Janus kinase inhibitors Meta-analysis outcome patients patients with COVID-19 performed positive pressure ventilation progression PROSPERO database random-effects model randomised controlled trial RCT reduce mortality reduced Registered Respiratory failure searched severe disease shown Standard of care Standard therapy statistically significant statistically significant reduction Tocilizumab Treatment with COVID-19 [DOI] 10.1016/j.eclinm.2022.101489 [Article Type] Research article
Evaluating Polish nurses’ working conditions and patient safety during the COVID-19 pandemicObservational Study Published on 2022-06-012022-10-05 Journal: International nursing review [Category] COVID19(2023년), SARS, 임상, [키워드] Affect affected Attitude attitudes to safety Care caused change condition conditions correlated COVID-19 COVID-19 pandemic COVID-19 patient Critical Culture Difficult effective Evaluating Factor healthcare Hospital staff hospitalised hospitalised patient Hospitalised patients hospitals imperative implication include Infection Isolation management non-infectious disease Nurse Nurses outbreak Patient patient safety polymerase chain professional Providing Psychological psychological support questionnaire Reinforcing Research Safe Safety SARS-CoV-2 test Satisfaction significantly statistically significant Stress STROBE Swab the SARS-CoV-2 virus Treatment was performed was used work conditions Working condition [DOI] 10.1111/inr.12724 PMC 바로가기 [Article Type] Observational Study